Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,427
Closed -$4.82M 37
2024
Q3
$4.82M Sell
14,427
-331
-2% -$126K 0.91% 30
2024
Q2
$6.08M Sell
14,758
-84
-0.6% -$33.3K 1.12% 30
2024
Q1
$6M Sell
14,842
-1,085
-7% -$381K 1.13% 28
2023
Q4
$4.88M Buy
+15,927
New +$4.3M 0.97% 30

Other funds holding MEDP

Ithaka Group's MEDP Position: Q4 2024 in Review

Ithaka Group sold out of Medpace (MEDP) in Q4 2024, closing a stake of 14,427 shares — an estimated $4.82M sold.

Ithaka Group first reported a position in MEDP in Q4 2023 and held it in 4 quarters. The position peaked at $6.08M in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Ithaka Group reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Ithaka Group sold 14,427 Medpace shares in Q4 2024, an estimated $4.82M.
  • Ithaka Group first reported a position in Medpace in Q4 2023 and held it in 4 quarters.
  • Ithaka Group's Medpace position peaked at $6.08M in Q2 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Ithaka Group's 13F filing for Q4 2024, filed 10 Feb 2025.